The changing pattern of hepatitis A in Lebanese adults

International Journal of Infectious Diseases

Volumn 30, Issue , 2015, Pages 87-90

  Melhem, Nada M ^a   Jaffa, Miran ^a   Zaatari, Mohamad ^b   Awada, Hanane ^a   Salibi, Noura El ^a   Ramia, Sami ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Hammoud Hospital   (Lebanon)

Author keywords

Anti HAV antibodies; Epidemiologic shift; Hepatitis a virus; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; HEPATITIS A ANTIBODY;

ACUTE HEPATITIS; ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; CHILD; CONVENIENCE SAMPLE; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMAN EXPERIMENT; HYGIENE; LEBANESE; LEBANON; MALE; NORMAL HUMAN; PREVALENCE; RISK FACTOR; SEROPREVALENCE; SOCIAL STATUS; ACUTE DISEASE; BLOOD; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ACUTE DISEASE; ADULT; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; LEBANON; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84918537670     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.10.007     Document Type: Article

References (30)

1. Naoumov N.V. Hepatitis A and E. Medicine 2007, 35:35-38.
2. Jacobsen K.H., Wiersma S.T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010, 28:6653-6657.
3. Fiore A.E. Hepatitis A transmitted by food. Clin Infect Dis 2004, 38:705-715.
4. Fiore A.E., Wasely A., Bell B.P. Prevention of hepatitis A through active or passive immunization. MMWR Recomm Rep 2006, 55:1-23.
5. Jacobsen K.H., Koopman J.S. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 2005, 34:600-609.
6. Melhem N.M., Talhouk R., Rachidi H., Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat 2014, 21:605-615.
7. UNHCR. Syrian regional refugee response inter-agency information sharing portal. UNHCR 2014; Available at: (accessed May 5, 2014). http://data.unhcr.org/syrianrefugees/regional.php.
8. The Lebanese Ministry of Public Health (MOPH) 2014. Available at: (accessed May 20, 2014). http://www.moph.gov.lb/Pages/Home.aspx.
9. WHO position paper on hepatitis A vaccines: June 2012-recommendations. Vaccine 2013;31:285-6.
10. Sacy R.G., Haddad M., Baasiri G., Khoriati A., Gerbaka B.J., Abu-Elyazeed R. Hepatitis A in Lebanon: a changing epidemiological pattern. Am J Trop Med Hyg 2005, 73:453-456.
11. World Health Organization The global prevalence of hepatitis A virus infection and susceptibility: a systematic review 2009, WHO, Geneva, Switzerland.
12. Al Faleh F., Al Shehri S., Al Ansari S., Al Jeffri M., Al Mazrou Y., Shaffi A. Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years. World J Gastroenterol 2008, 14:7371-7375.
13. Alkhalidi J., Alenezi B., Al-Mufti S., Hussain E., Askar H., Kemmer N. Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol 2009, 15:102-105.
14. Sharar Z., Rajah J., Parsons H. Childhood seroprevalence of hepatitis A in the United Arab Emirates. Trop Doct 2008, 38:65-66.
15. Alian S., Ajami A., Ghasemian R., Yadegarinia D. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J 2011, 17:754-758.
16. Ardakani A., Soltani B., Sehat M., Namjoo S., Haji Rezaei M. Seroprevalence of anti-hepatitis A antibody among 1-15 year old children in Kashan-Iran. Hepat Mon 2013, 13:e10553.
17. Merat S., Rezvan H., Nouraie M., Abolghasemi H., Jamali R., Amini-Kafiabad S., et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med 2010, 13:99-104.
18. Mohebbi S.R., Rostami Nejad M., Tahaei S.M., Pourhoseingholi M.A., Habibi M., Azimzadeh P., et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg 2012, 106:528-531.
19. Saffar M.J., Abedian O., Ajami A., Abedian F., Mirabi A.M., Khalilian A.R., et al. Age-specific seroprevalence of anti-hepatitis A antibody among 1-30 years old population of Savadkuh, Mazandaran, Iran with literature review. Hepat Mon 2012, 12:326-332.
20. Sofian M., Aghakhani A., Farazi A.A., Banifazl M., Etemadi G., Azad-Armaki S., et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis 2010, 8:176-179.
21. Taghavi S.A., Hosseini Asl M.K., Talebzadeh M., Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon 2011, 11:285-288.
22. Turky A.M., Akram W., Al-Naaimi A.S. Analysis of acute viral hepatitis (A and E) in Iraq. Global J Health Sci 2011, 3:70-76.
23. El-Gilany A.H., Hammad S., Refaat K., Al-Enazi R. Seroprevalence of hepatitis A antibodies among children in a Saudi community. Asian Pacific J Trop Med 2010, 3:278-282.
24. Deveci U., Ustun C., Hamanca O. Seroprevalence of hepatitis-A virus among children aged 1-16 years in Eastern Anatolia, Turkey. Afr J Microbiol Res 2011, 5:5969-5971.
25. Ince O.T., Yalcin S.S., Yurdakök K., Ozmert E.N. Hepatitis A seroprevalence among infants aged 12 months in Ankara. Turk J Pediatr 2011, 53:114-116.
26. Topal E., Hatipoglu N., Turel O., Aydogmus C., Hatipoglu H., Erkal S., et al. Seroprevalence of hepatitis A and hepatitis A vaccination rate in preschool age in Istanbul urban. J Pediatr Infect 2011, 5:12-15.
27. Halicioglu O., Akman S.A., Tatar B., Atesli R., Kose S. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis 2012, 10:43-47.
28. Ceran N., Yüksel Kocdogan F., Mert D., Erdem I., Dede B., Adaleti R. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat 2012, 19:72-76.
29. UNICEF, World Health Organization. Immunization summary 2013. UNICEF 2013;. Available at: (accessed May 5, 2014). http://www.unicef.org/videoaudio/PDFs/EN-ImmSumm-2013.pdf.
30. Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol 2012, 55:296-302.